Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR, ZFN, TALEN), By Delivery Method, By Application, By Mode, By End-use, By Region, And Segment Forecasts, 2021 - 2028

Market Segmentation

• Genome Editing Technology Outlook (Revenue, USD Million, 2017 - 2028)
  • (CRISPR)/Cas9
  • TALENs/MegaTALs
  • ZFN
  • Meganucleases
  • Others
• Genome Editing Delivery Method Outlook (Revenue, USD Million, 2017 - 2028)
  • Ex-vivo
  • In-vivo
• Genome Editing Application Outlook (Revenue, USD Million, 2017 - 2028)
  • Genetic Engineering
    • Cell line engineering
    • Animal genetic engineering
    • Plant genetic engineering
    • Others
  • Clinical Applications
    • Diagnostics
    • Therapy Development
• Genome Editing Mode Outlook (Revenue, USD Million, 2017 - 2028)
  • Contract
  • In-house
• Genome Editing End-use Outlook (Revenue, USD Million, 2017 - 2028)
  • Biotechnology and pharmaceutical companies
  • Academic and government research institutes
  • Contract research organizations
• Genome Editing Regional Outlook (Revenue, USD Million, 2017 - 2028)
  • North America
    • North America Genome Editing Market, By Technology
      • Mega-nucleases
      • (CRISPR)/Cas9
      • TALENs/MegaTALs
      • ZFN
      • Others
    • North America Genome Editing Market, By Delivery Method
      • Ex-vivo
      • In-vivo
    • North America Genome Editing Market, By Application
      • Genetic Engineering
        • Cell line engineering
        • Animal genetic engineering
        • Plant genetic engineering
        • Others
      • Clinical Applications
        • Diagnostics
        • Therapy Development
    • North America Genome Editing Market, By mode
    • Contract
    • In-house
    • North America Genome Editing Market, By End use
      • Biotechnology and pharmaceutical companies
      • Academic and government research institutes
      • Contract research organizations
    • U.S.
    • U.S. Genome Editing Market, By Technology
      • Mega-nucleases
      • (CRISPR)/Cas9
      • TALENs/MegaTALs
      • ZFN
      • Others
    • U.S. Genome Editing Market, By Delivery Method
      • Ex-vivo
      • In-vivo
    • U.S. Genome Editing Market, By Application
      • Genetic Engineering
      • Cell line engineering
      • Animal genetic engineering
      • Plant genetic engineering
      • Others
      • Clinical Applications
      • Diagnostics
      • Therapy development
    • U.S. Genome Editing Market, By mode
      • Contract
      • In-house
    • U.S. Genome Editing Market, By End use
      • Biotechnology and pharmaceutical companies
      • Academic and government research institutes
      • Contract research organizations
    • Canada
      • Canada Genome Editing Market, By Technology
        • Mega-nucleases
        • (CRISPR)/Cas9
        • TALENs/MegaTALs
        • ZFN
        • Others
      • Canada Genome Editing Market, By Delivery Method
        • Ex-vivo
        • In-vivo
      • Canada Genome Editing Market, By Application
        • Genetic Engineering
        • Cell line engineering
        • Animal genetic engineering
        • Plant genetic engineering
        • Others
        • Clinical Applications
        • Diagnostics
        • Therapy development
      • Canada Genome Editing Market, By mode
        • Contract
        • In-house
      • Canada Genome Editing Market, By End use
        • Biotechnology and pharmaceutical companies
        • Academic and government research institutes
        • Contract research organizations
  • Europe
    • Europe Genome Editing Market, By Technology
      • Mega-nucleases
      • (CRISPR)/Cas9
      • TALENs/MegaTALs
      • ZFN
      • Others
    • Europe Genome Editing Market, By Delivery Method
      • Ex-vivo
      • In-vivo
    • Europe Genome Editing Market, By Application
      • Genetic Engineering
      • Cell line engineering
      • Animal genetic engineering
      • Plant genetic engineering
      • Others
      • Clinical Applications
      • Diagnostics
      • Therapy development
    • Europe Genome Editing Market, By mode
      • Contract
      • In-house
    • Europe Genome Editing Market, By End use
      • Biotechnology and pharmaceutical companies
      • Academic and government research institutes
      • Contract research organizations
    • Germany
      • Germany Genome Editing Market, By Technology
        • Mega-nucleases
        • (CRISPR)/Cas9
        • TALENs/MegaTALs
        • ZFN
        • Others
      • Germany Genome Editing Market, By Delivery Method
        • Ex-vivo
        • In-vivo
      • Germany Genome Editing Market, By Application
        • Genetic Engineering
        • Cell line engineering
        • Animal genetic engineering
        • Plant genetic engineering
        • Others
        • Clinical Applications
        • Diagnostics
        • Therapy development
      • Germany Genome Editing Market, By mode
        • Contract
        • In-house
      • Germany Genome Editing Market, By End use
        • Biotechnology and pharmaceutical companies
        • Academic and government research institutes
        • Contract research organizations
    • U.K.
      • U.K. Genome Editing Market, By Technology
        • Mega-nucleases
        • (CRISPR)/Cas9
        • TALENs/MegaTALs
        • ZFN
        • Others
      • U.K. Genome Editing Market, By Delivery Method
        • Ex-vivo
        • In-vivo
      • U.K. Genome Editing Market, By Application
        • Genetic Engineering
        • Cell line engineering
        • Animal genetic engineering
        • Plant genetic engineering
        • Others
        • Clinical Applications
        • Diagnostics
        • Therapy development
      • U.K. Genome Editing Market, By mode
        • Contract
        • In-house
      • U.K. Genome Editing Market, By End use
        • Biotechnology and pharmaceutical companies
        • Academic and government research institutes
        • Contract research organizations
    • France
      • France Genome Editing Market, By Technology
        • Mega-nucleases
        • (CRISPR)/Cas9
        • TALENs/MegaTALs
        • ZFN
        • Others
      • France Genome Editing Market, By Delivery Method
        • Ex-vivo
        • In-vivo
      • France Genome Editing Market, By Application
        • Genetic Engineering
        • Cell line engineering
        • Animal genetic engineering
        • Plant genetic engineering
        • Others
        • Clinical Applications
        • Diagnostics
        • Therapy development
      • France Genome Editing Market, By mode
        • Contract
        • In-house
      • France Genome Editing Market, By End use
        • Biotechnology and pharmaceutical companies
        • Academic and government research institutes
        • Contract research organizations
    • Italy
      • Italy Genome Editing Market, By Technology
        • Mega-nucleases
        • (CRISPR)/Cas9
        • TALENs/MegaTALs
        • ZFN
        • Others
      • Italy Genome Editing Market, By Delivery Method
        • Ex-vivo
        • In-vivo
      • Italy Genome Editing Market, By Application
        • Genetic Engineering
        • Cell line engineering
        • Animal genetic engineering
        • Plant genetic engineering
        • Others
        • Clinical Applications
        • Diagnostics
        • Therapy development
      • Italy Genome Editing Market, By mode
        • Contract
        • In-house
      • Italy Genome Editing Market, By End use
        • Biotechnology and pharmaceutical companies
        • Academic and government research institutes
        • Contract research organizations
    • Spain
      • Spain Genome Editing Market, By Technology
        • Mega-nucleases
        • (CRISPR)/Cas9
        • TALENs/MegaTALs
        • ZFN
        • Others
      • Spain Genome Editing Market, By Delivery Method
        • Ex-vivo
        • In-vivo
      • Spain Genome Editing Market, By Application
        • Genetic Engineering
        • Cell line engineering
        • Animal genetic engineering
        • Plant genetic engineering
        • Others
        • Clinical Applications
        • Diagnostics
        • Therapy development
      • Spain Genome Editing Market, By mode
        • Contract
        • In-house
      • Spain Genome Editing Market, By End use
        • Biotechnology and pharmaceutical companies
        • Academic and government research institutes
        • Contract research organizations
  • Asia Pacific
    • Asia Pacific Genome Editing Market, By Technology
      • Mega-nucleases
      • (CRISPR)/Cas9
      • TALENs/MegaTALs
      • ZFN
      • Others
    • Asia Pacific Genome Editing Market, By Delivery Method
      • Ex-vivo
      • In-vivo
    • Asia Pacific Genome Editing Market, By Application
      • Genetic Engineering
      • Cell line engineering
      • Animal genetic engineering
      • Plant genetic engineering
      • Others
      • Clinical Applications
      • Diagnostics
      • Therapy development
    • Asia Pacific Genome Editing Market, By mode
      • Contract
      • In-house
    • Asia Pacific Genome Editing Market, By End use
      • Biotechnology and pharmaceutical companies
      • Academic and government research institutes
      • Contract research organizations
    • Japan
      • Japan Genome Editing Market, By Technology
        • Mega-nucleases
        • (CRISPR)/Cas9
        • TALENs/MegaTALs
        • ZFN
        • Others
      • Japan Genome Editing Market, By Delivery Method
        • Ex-vivo
        • In-vivo
      • Japan Genome Editing Market, By Application
        • Genetic Engineering
        • Cell line engineering
        • Animal genetic engineering
        • Plant genetic engineering
        • Others
        • Clinical Applications
        • Diagnostics
        • Therapy development
      • Japan Genome Editing Market, By mode
        • Contract
        • In-house
      • Japan Genome Editing Market, By End use
        • Biotechnology and pharmaceutical companies
        • Academic and government research institutes
        • Contract research organizations
    • China
      • China Genome Editing Market, By Technology
        • Mega-nucleases
        • (CRISPR)/Cas9
        • TALENs/MegaTALs
        • ZFN
        • Others
      • China Genome Editing Market, By Delivery Method
        • Ex-vivo
        • In-vivo
      • China Genome Editing Market, By Application
        • Genetic Engineering
        • Cell line engineering
        • Animal genetic engineering
        • Plant genetic engineering
        • Others
        • Clinical Applications
        • Diagnostics
        • Therapy development
      • China Genome Editing Market, By mode
        • Contract
        • In-house
      • China Genome Editing Market, By End use
        • Biotechnology and pharmaceutical companies
        • Academic and government research institutes
        • Contract research organizations
    • India
      • India Genome Editing Market, By Technology
        • Mega-nucleases
        • (CRISPR)/Cas9
        • TALENs/MegaTALs
        • ZFN
        • Others
      • India Genome Editing Market, By Delivery Method
        • Ex-vivo
        • In-vivo
      • India Genome Editing Market, By Application
        • Genetic Engineering
        • Cell line engineering
        • Animal genetic engineering
        • Plant genetic engineering
        • Others
        • Clinical Applications
        • Diagnostics
        • Therapy development
      • India Genome Editing Market, By mode
        • Contract
        • In-house
      • India Genome Editing Market, By End use
        • Biotechnology and pharmaceutical companies
        • Academic and government research institutes
        • Contract research organizations
    • South Korea
      • South Korea Genome Editing Market, By Technology
        • Mega-nucleases
        • (CRISPR)/Cas9
        • TALENs/MegaTALs
        • ZFN
        • Others
      • South Korea Genome Editing Market, By Delivery Method
        • Ex-vivo
        • In-vivo
      • South Korea Genome Editing Market, By Application
        • Genetic Engineering
        • Cell line engineering
        • Animal genetic engineering
        • Plant genetic engineering
        • Others
        • Clinical Applications
        • Diagnostics
        • Therapy development
      • South Korea Genome Editing Market, By mode
        • Contract
        • In-house
      • South Korea Genome Editing Market, By End use
        • Biotechnology and pharmaceutical companies
        • Academic and government research institutes
        • Contract research organizations
  • Latin America
    • Latin America Genome Editing Market, By Technology
      • Mega-nucleases
      • (CRISPR)/Cas9
      • TALENs/MegaTALs
      • ZFN
      • Others
    • Latin America Genome Editing Market, By Delivery Method
      • Ex-vivo
      • In-vivo
    • Latin America Genome Editing Market, By Application
      • Genetic Engineering
      • Cell line engineering
      • Animal genetic engineering
      • Plant genetic engineering
      • Others
      • Clinical Applications
      • Diagnostics
      • Therapy development
    • Latin America Genome Editing Market, By mode
      • Contract
      • In-house
    • Latin America Genome Editing Market, By End use
      • Biotechnology and pharmaceutical companies
      • Academic and government research institutes
      • Contract research organizations
    • Brazil
      • Brazil Genome Editing Market, By Technology
        • Mega-nucleases
        • (CRISPR)/Cas9
        • TALENs/MegaTALs
        • ZFN
        • Others
      • Brazil Genome Editing Market, By Delivery Method
        • Ex-vivo
        • In-vivo
      • Brazil Genome Editing Market, By Application
        • Genetic Engineering
        • Cell line engineering
        • Animal genetic engineering
        • Plant genetic engineering
        • Others
        • Clinical Applications
        • Diagnostics
        • Therapy development
      • Brazil Genome Editing Market, By mode
        • Contract
        • In-house
      • Brazil Genome Editing Market, By End use
        • Biotechnology and pharmaceutical companies
        • Academic and government research institutes
        • Contract research organizations
    • Mexico
      • Mexico Genome Editing Market, By Technology
        • Mega-nucleases
        • (CRISPR)/Cas9
        • TALENs/MegaTALs
        • ZFN
        • Others
      • Mexico Genome Editing Market, By Delivery Method
        • Ex-vivo
        • In-vivo
      • Mexico Genome Editing Market, By Application
        • Genetic Engineering
        • Cell line engineering
        • Animal genetic engineering
        • Plant genetic engineering
        • Others
        • Clinical Applications
        • Diagnostics
        • Therapy development
      • Mexico Genome Editing Market, By mode
        • Contract
        • In-house
      • Mexico Genome Editing Market, By End use
        • Biotechnology and pharmaceutical companies
        • Academic and government research institutes
        • Contract research organizations
  • Middle East and Africa (MEA)
    • Middle East and Africa Genome Editing Market, By Technology
      • Mega-nucleases
      • (CRISPR)/Cas9
      • TALENs/MegaTALs
      • ZFN
      • Others
    • Middle East and Africa Genome Editing Market, By Delivery Method
      • Ex-vivo
      • In-vivo
    • Middle East and Africa Genome Editing Market, By Application
      • Genetic Engineering
      • Cell line engineering
      • Animal genetic engineering
      • Plant genetic engineering
      • Others
      • Clinical Applications
      • Diagnostics
      • Therapy development
    • Middle East and Africa Genome Editing Market, By mode
      • Contract
      • In-house
    • Middle East and Africa Genome Editing Market, By End use
      • Biotechnology and pharmaceutical companies
      • Academic and government research institutes
      • Contract research organizations
    • South Africa
      • South Africa Genome Editing Market, By Technology
        • Mega-nucleases
        • (CRISPR)/Cas9
        • TALENs/MegaTALs
        • ZFN
        • Others
      • South Africa Genome Editing Market, By Delivery Method
        • Ex-vivo
        • In-vivo
      • South Africa Genome Editing Market, By Application
        • Genetic Engineering
        • Cell line engineering
        • Animal genetic engineering
        • Plant genetic engineering
        • Others
        • Clinical Applications
        • Diagnostics
        • Therapy development
      • South Africa Genome Editing Market, By mode
        • Contract
        • In-house
      • South Africa Genome Editing Market, By End use
        • Biotechnology and pharmaceutical companies
        • Academic and government research institutes
        • Contract research organizations
    • Saudi Arabia
      • Saudi Arabia Genome Editing Market, By Technology
        • Mega-nucleases
        • (CRISPR)/Cas9
        • TALENs/MegaTALs
        • ZFN
        • Others
      • Saudi Arabia Genome Editing Market, By Delivery Method
        • Ex-vivo
        • In-vivo
      • Saudi Arabia Genome Editing Market, By Application
        • Genetic Engineering
        • Cell line engineering
        • Animal genetic engineering
        • Plant genetic engineering
        • Others
        • Clinical Applications
        • Diagnostics
        • Therapy development
      • Saudi Arabia Genome Editing Market, By mode
        • Contract
        • In-house
      • Saudi Arabia Genome Editing Market, By End use
        • Biotechnology and pharmaceutical companies
        • Academic and government research institutes
        • Contract research organizations

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• 乐鱼体育手机网站入口
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2017 to 2028
• Market estimates and forecast for product segments up to 2028
• Regional market size and forecast for product segments up to 2028
• Market estimates and forecast for application segments up to 2028
• Regional market size and forecast for application segments up to 2028
• Company financial performance